6533b856fe1ef96bd12b30b4

RESEARCH PRODUCT

Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates.

John HiscottJohn HiscottMeztli Arguello

subject

Cancer ResearchProteasesCellPeptideBiologyMicrobiologyArticleOvarian tumorViral ProteinsUbiquitinImmunology and Microbiology(all)VirologymedicineHumansMolecular BiologyUbiquitinschemistry.chemical_classificationVirologyISG15Immunity InnateCell biologyNeoplasm ProteinsProtein Structure Tertiarymedicine.anatomical_structureViral replicationchemistrybiology.proteinCytokinesParasitologyConjugatePeptide HydrolasesSignal Transduction

description

Ubiquitin (Ub) and interferon stimulated gene product 15 (ISG15) reversibly conjugate to proteins via a conserved LRLRGG C-terminal motif, mediating important innate antiviral responses. The ovarian tumor (OTU) domain represents a superfamily of predicted proteases found in eukaryotic, bacterial and viral proteins, some of which have Ub-deconjugating activity. We show that the OTU domain-containing proteases of nairoviruses and arteriviruses hydrolyze Ub and ISG15 from cellular target proteins. This broad activity contrasts with the target specificity of known mammalian OTU domain-containing proteins. The biological significance of this activity of viral OTU domain-containing proteases was evidenced by their capacity to inhibit NF-κB dependent signaling and to antagonize the antiviral effects of ISG15 during Sindbis virus infection in vivo. The deconjugating activity of viral OTU proteases represents a novel viral immune evasion mechanism that inhibits Ub-and ISG15-dependent antiviral pathways.

10.1016/j.chom.2007.11.005https://pubmed.ncbi.nlm.nih.gov/18078692